Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 92.3 pp 561-573
DOI: 10.1113/expphysiol.2006.035790
© The Physiological Society 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/3/561    most recent
expphysiol.2006.035790v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, I. J.
Right arrow Articles by Dodd, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, I. J.
Right arrow Articles by Dodd, S. L.
Related Collections
Right arrow Muscle
Muscle

Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle

Ira J. Smith1 and Stephen L. Dodd1

1 Muscle Physiology Laboratory, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA

The role of the calpain proteases in skeletal muscle atrophy is poorly understood. One goal of these experiments was to clarify whether calpains act upstream of the ubiquitin–proteasome pathway (UPP). Calpain activation may also inhibit the anabolic signalling of Akt, since a molecular chaperone previously shown to mediate Akt activity, heat shock protein 90 (HSP 90), is a calpain substrate. Thus, an additional objective was to determine whether calpain activation affects the Akt signalling pathway. Ex vivo experiments were conducted using isolated rat diaphragm muscle. Calpain activation increased total protein degradation by 65%. Proteasome inhibition prevented this large rise in proteolysis, demonstrating that the proteasome was necessary for calpain-activated protein degradation. In addition, calpain activation increased proteasome-dependent proteolysis by 144%, further supporting the idea of sequential proteolytic pathways. Calpain reduced Akt and mammalian target of rapamycin (mTOR) phosphorylation by 35 and 50%, respectively, and activated glycogen synthase kinase-3 beta (GSK-3ß) by 40%. Additionally, calpain activation reduced HSP 90ß and mTOR protein content by 33 and 50%, respectively. These data suggest that calpains play a dual role in protein metabolism by concomitantly activating proteasome-dependent proteolysis and inhibiting the Akt pathway of protein synthesis.

(Received 18 September 2006; accepted after revision 1 February 2007; first published online 1 February 2007)
Corresponding author I. J. Smith: GSRB-1, Room 1043, 595 LaSalle Street, Duke University, Durham, NC 27710, USA. Email: ira4{at}duke.edu




This article has been cited by other articles:


Home page
J ANIM SCIHome page
D. E. Goll, G. Neti, S. W. Mares, and V. F. Thompson
Myofibrillar protein turnover: The proteasome and the calpains
J Anim Sci, April 1, 2008; 86(14_suppl): E19 - E35.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Barker and M. G. Traber
From animals to humans: evidence linking oxidative stress as a causative factor in muscle atrophy
J. Physiol., September 1, 2007; 583(2): 421 - 422.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the The Physiological Society.